The recent disruptions in global chains have highlighted the necessity of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes nations to significant vulnerabilities, including shipping delays, price fluctuations, and even trade concerns. Moving towards domestic procurement of Ivermectin offers a multitude of